Wave Life Sciences Income Statement (2015-2026) | WVE

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
2.78M36.42M77.90M1.75M0.38M0.28M81.20M12.93M22.11M49.21M128.20M12.54M19.69M199.50M9.18M8.70M38.25M
Operating items
Research & Development (Quarter)
31.64M31.09M25.76M27.47M29.73M27.57M31.08M30.98M33.31M31.64M34.07M33.45M40.39M41.20M44.65M40.62M43.47M45.87M52.81M47.44M
Selling, General & Administrative (Quarter)
10.97M12.94M12.11M12.37M12.81M11.61M13.72M12.23M12.27M13.13M13.66M13.55M14.30M15.04M16.14M18.36M17.99M18.09M20.90M22.10M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
42.60M44.03M37.88M39.84M42.54M39.18M44.80M43.21M45.58M44.77M47.74M47.00M54.69M56.24M60.78M58.98M61.46M63.96M73.71M69.54M
Operating Income (Quarter)
-39.83M-7.61M-36.11M-38.09M-42.16M-38.90M-43.56M-30.29M-23.47M4.44M-18.68M-34.46M-35.00M-63.91M22.97M-49.80M-52.76M-56.35M-56.47M-31.30M
EBIT (Quarter)
-39.83M-7.61M-36.11M-38.09M-42.16M-38.90M-43.56M-30.29M-23.47M4.44M-18.68M-34.46M-35.00M-63.91M22.97M-49.80M-52.76M-56.35M-56.47M-31.30M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.01M0.03M0.12M0.60M0.82M1.87M2.25M1.96M1.84M2.54M2.09M1.80M3.74M2.88M2.37M2.18M3.05M5.29M
Other Non Operating Income (Quarter)
1.05M1.37M1.12M0.25M0.74M-0.70M-0.29M1.01M0.12M0.17M0.58M0.36M-0.02M0.34M2.55M0.05M-0.08M0.32M0.23M-0.08M
Non Operating Income (Quarter)
1.05M1.38M1.12M0.28M0.74M-0.10M-1.04M2.88M2.37M0.17M8.51M2.90M-0.02M0.34M-3.88M2.93M-0.08M0.32M3.29M-0.08M
Net income details
EBT (Quarter)
-38.77M-6.23M-34.99M-37.81M-41.30M-39.00M-43.03M-27.41M-21.10M6.58M-16.26M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M
Tax Provisions (Quarter)
-0.20M0.68M-0.70M
Profit After Tax (Quarter)
-38.77M-6.23M-34.78M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.25M-16.26M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M
Income from Continuing Operations (Quarter)
-38.77M-6.23M-34.78M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.28M-16.26M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M
Consolidated Net Income (Quarter)
-38.77M-6.23M-34.78M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.28M-16.26M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M
Income towards Parent Company (Quarter)
-38.77M-6.23M-34.78M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.28M-16.26M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M
Net Income towards Common Stockholders (Quarter)
-38.77M-6.23M-34.78M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.28M-16.26M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M
Additional items
EPS (Basic) (Quarter)
-0.78-0.12-0.61-0.62-0.62-0.42-0.45-0.27-0.200.07-0.15-0.24-0.25-0.470.27-0.29-0.31-0.32-0.29-0.13
EPS (Weighted Average and Diluted) (Quarter)
-0.78-0.12-0.61-0.62-0.62-0.42-0.45-0.27-0.200.07-0.15-0.24-0.25-0.470.27-0.29-0.31-0.32-0.29-0.13
Shares Outstanding (Weighted Average) (Quarter)
49.22M50.02M51.83M60.52M7.09M93.90M78.86M102.06M103.77M104.53M106.10M129.27M129.40M132.56M138.28M8.97M163.27M164.77M168.65M11.60M
Shares Outstanding (Diluted Average) (Quarter)
49.97M50.02M51.83M60.52M63.51M73.75M78.86M102.06M105.46M106.10M129.27M129.40M132.56M138.28M162.53M163.99M167.74M168.65M200.17M
EBITDA (Quarter)
-38.77M-6.24M-34.86M-37.90M-41.44M-39.08M-43.62M-27.43M-21.20M7.22M-16.20M-31.63M-33.00M-61.66M29.15M-46.82M-50.43M-53.88M-53.24M-26.09M
Tax Rate (Quarter)
0.58%-1.58%-10.65%